Format
Sort by

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 147

1.

The cellular antiviral protein APOBEC3G interacts with HIV-1 reverse transcriptase and inhibits its function during viral replication.

Wang X, Ao Z, Chen L, Kobinger G, Peng J, Yao X.

J Virol. 2012 Apr;86(7):3777-86. doi: 10.1128/JVI.06594-11. Epub 2012 Feb 1.

2.

The HIV-1 central polypurine tract functions as a second line of defense against APOBEC3G/F.

Hu C, Saenz DT, Fadel HJ, Walker W, Peretz M, Poeschla EM.

J Virol. 2010 Nov;84(22):11981-93. doi: 10.1128/JVI.00723-10. Epub 2010 Sep 15.

3.

Small-molecule inhibition of human immunodeficiency virus type 1 replication by targeting the interaction between Vif and ElonginC.

Zuo T, Liu D, Lv W, Wang X, Wang J, Lv M, Huang W, Wu J, Zhang H, Jin H, Zhang L, Kong W, Yu X.

J Virol. 2012 May;86(10):5497-507. doi: 10.1128/JVI.06957-11. Epub 2012 Feb 29.

4.

Induction of heat-shock protein 70 by prostaglandin A₁ inhibits HIV-1 Vif-mediated degradation of APOBEC3G.

Sugiyama R, Abe M, Nishitsuji H, Murakami Y, Takeuchi H, Takaku H.

Antiviral Res. 2013 Sep;99(3):307-11. doi: 10.1016/j.antiviral.2013.06.017. Epub 2013 Jul 4.

PMID:
23831493
5.

The antiviral factor APOBEC3G improves CTL recognition of cultured HIV-infected T cells.

Casartelli N, Guivel-Benhassine F, Bouziat R, Brandler S, Schwartz O, Moris A.

J Exp Med. 2010 Jan 18;207(1):39-49. doi: 10.1084/jem.20091933. Epub 2009 Dec 28.

6.

APOBEC3G and APOBEC3F require an endogenous cofactor to block HIV-1 replication.

Han Y, Wang X, Dang Y, Zheng YH.

PLoS Pathog. 2008 Jul 4;4(7):e1000095. doi: 10.1371/journal.ppat.1000095.

7.

APOBEC3G inhibits elongation of HIV-1 reverse transcripts.

Bishop KN, Verma M, Kim EY, Wolinsky SM, Malim MH.

PLoS Pathog. 2008 Dec;4(12):e1000231. doi: 10.1371/journal.ppat.1000231. Epub 2008 Dec 5.

8.

Vpr14-88-Apobec3G fusion protein is efficiently incorporated into Vif-positive HIV-1 particles and inhibits viral infection.

Ao Z, Yu Z, Wang L, Zheng Y, Yao X.

PLoS One. 2008 Apr 16;3(4):e1995. doi: 10.1371/journal.pone.0001995.

9.

Characterization of conserved motifs in HIV-1 Vif required for APOBEC3G and APOBEC3F interaction.

He Z, Zhang W, Chen G, Xu R, Yu XF.

J Mol Biol. 2008 Sep 12;381(4):1000-11. doi: 10.1016/j.jmb.2008.06.061. Epub 2008 Jun 28.

PMID:
18619467
10.

Deaminase-independent inhibition of HIV-1 reverse transcription by APOBEC3G.

Iwatani Y, Chan DS, Wang F, Maynard KS, Sugiura W, Gronenborn AM, Rouzina I, Williams MC, Musier-Forsyth K, Levin JG.

Nucleic Acids Res. 2007;35(21):7096-108. Epub 2007 Oct 16.

11.

APOBEC3G inhibits HIV-1 RNA elongation by inactivating the viral trans-activation response element.

Nowarski R, Prabhu P, Kenig E, Smith Y, Britan-Rosich E, Kotler M.

J Mol Biol. 2014 Jul 29;426(15):2840-53. doi: 10.1016/j.jmb.2014.05.012. Epub 2014 May 21.

12.

Identification of a critical T(Q/D/E)x5ADx2(I/L) motif from primate lentivirus Vif proteins that regulate APOBEC3G and APOBEC3F neutralizing activity.

Dang Y, Wang X, York IA, Zheng YH.

J Virol. 2010 Sep;84(17):8561-70. doi: 10.1128/JVI.00960-10. Epub 2010 Jun 30.

13.

Estimating the fraction of progeny virions that must incorporate APOBEC3G for suppression of productive HIV-1 infection.

Thangavelu PU, Gupta V, Dixit NM.

Virology. 2014 Jan 20;449:224-8. doi: 10.1016/j.virol.2013.11.026. Epub 2013 Dec 10.

14.

Multi-scale modeling of HIV infection in vitro and APOBEC3G-based anti-retroviral therapy.

Hosseini I, Mac Gabhann F.

PLoS Comput Biol. 2012 Feb;8(2):e1002371. doi: 10.1371/journal.pcbi.1002371. Epub 2012 Feb 9.

15.

APOBEC3G impairs the multimerization of the HIV-1 Vif protein in living cells.

Batisse J, Guerrero SX, Bernacchi S, Richert L, Godet J, Goldschmidt V, Mély Y, Marquet R, de Rocquigny H, Paillart JC.

J Virol. 2013 Jun;87(11):6492-506. doi: 10.1128/JVI.03494-12. Epub 2013 Apr 10.

16.

[Advances in the study of molecular mechanism of APOBEC3G anti-HIV-1].

Fan B, Cen S, Jiang JD.

Yao Xue Xue Bao. 2008 Jul;43(7):678-82. Review. Chinese.

PMID:
18819469
17.

Intracellular interactions between APOBEC3G, RNA, and HIV-1 Gag: APOBEC3G multimerization is dependent on its association with RNA.

Friew YN, Boyko V, Hu WS, Pathak VK.

Retrovirology. 2009 Jun 4;6:56. doi: 10.1186/1742-4690-6-56.

18.

The anti-HIV-1 editing enzyme APOBEC3G binds HIV-1 RNA and messenger RNAs that shuttle between polysomes and stress granules.

Kozak SL, Marin M, Rose KM, Bystrom C, Kabat D.

J Biol Chem. 2006 Sep 29;281(39):29105-19. Epub 2006 Aug 3.

19.
20.

APOBEC3G: a double agent in defense.

Smith HC.

Trends Biochem Sci. 2011 May;36(5):239-44. doi: 10.1016/j.tibs.2010.12.003. Epub 2011 Jan 14.

Items per page

Supplemental Content

Write to the Help Desk